Therapeutic Efficacy of Autologous Platelet Concentrate Injection on Macular Holes with High Myopia, Large Macular Holes, or Recurrent Macular Holes: A Multicenter Randomized Controlled Trial

COMMENTED

Macular DiseasesSurgery and Intervention

Facedown Positioning Following Surgery for Large Full-Thickness Macular Hole: A Multicenter Randomized Clinical Trial

★ 2 Recommended and commented by Prof. Dr Stephan Michels, Faculty Member

★ 3 Recommended by Prof. Dr Ke Yao, Faculty Member

doi: 10.1001/jamaophthalmol.2020.0987.

COMMENTED

Blindness and Vision Impairment

Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control

Ophthalmology.

Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, Ko ST, Young AL, Tham CC, Chen LJ, Pang CP

doi: 10.1016/j.

Macular Diseases

THE CURRENT SURGICAL MANAGEMENT OF LARGE, RECURRENT, OR PERSISTENT MACULAR HOLES

Retina.

Tam ALC, Yan P, Gan NY, Lam WC

RECOMMENDED

Further Publications

Intravitreal Aflibercept Injection vs Sham as Prophylaxis Against Conversion to Exudative Age-Related Macular Degeneration in High-risk Eyes: A Randomized Clinical Trial

★ 3 Recommended by Prof. Dr Ke Yao, Faculty Member

JAMA Ophthalmol

Heier JS, Brown DM, Shah SP, Saroj N, Dang S, Waheed NK, Wykoff CC, Prenner JL, Boyer DS

doi: 10.1001/jamaophthalmol.2021.0221

Macular DiseasesRetinal Diseases

Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial

Ophthalmology.

Dugel PU, Tolentino M, Feiner L, Kozma P, Leroy A

doi: 10.1016/j.ophtha.2016.06.043.

Macular Diseases

Efficacy and safety of different agents, dosages and strategies of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: a network meta-analysis of randomized controlled trials

Acta Ophthalmol

Zhao XY, Meng LH, Liu SZ, Chen YX

doi: 10.1111/aos.14756

COMMENTED

Macular DiseasesRetinal Diseases

Autologous Retinal Transplantation for Primary and Refractory Macular Holes, and Macular Hole Retinal Detachments: The Global Consortium

★ 3 Recommended and commented by Dr habil. Gábor Márk Somfai, PhD, Faculty Member

Ophthalmology

Moysidis SN, Koulisis N, Adrean SD, Charles S, Chetty N, Chhablani JK, Cortes JC, Embabi SN, Gordon C, Gregori NZ, Habib A, Hamza H, Hassaan H, Hassan TS, Houghton O, Kadonosono K, Kusaka S, La Mantia A, Lai CC, Lumi X, Maeno T, Mahgoub MM, El Baha SM, Morales-Cantón V, Nowara M, Okonkwo ON, Parolini B, Rezende FA, Rogalinska I, Rojas S, Steel DH, Stopa M, Wu AL, Yamada K, Yamada M, Mahmoud TH

doi: 10.1016/j.ophtha.2020.10.007

Macular Diseases

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial

JAMA Ophthalmol.

Khanani AM, Patel SS, Ferrone PJ, Osborne A, Sahni J, Grzeschik S, Basu K, Ehrlich JS, Haskova Z, Dugel PU

doi: 10.1001/jamaophthalmol.

COMMENTED

Macular Diseases

Efficacy of a Treat-and-Extend Regimen With Ranibizumab in Patients With Neovascular Age-Related Macular Disease: A Randomized Clinical Trial

★ 3 Recommended by Prof. Dr Daniel Barthelmes, Faculty Member

★ 3 Recommended and commented by Prof. Dr Stephan Michels, Faculty Member

JAMA Ophthalmol.

Kertes PJ, Galic IJ, Greve M, Williams G, Baker J, Lahaie M, Sheidow T

doi: 10.1001/jamaophthalmol.2019.5540.

Related content

Facedown Positioning Following Surgery for Large Full-Thickness Macular Hole: A Multicenter Randomized Clinical Trial

Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control

THE CURRENT SURGICAL MANAGEMENT OF LARGE, RECURRENT, OR PERSISTENT MACULAR HOLES

Intravitreal Aflibercept Injection vs Sham as Prophylaxis Against Conversion to Exudative Age-Related Macular Degeneration in High-risk Eyes: A Randomized Clinical Trial

Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial

Efficacy and safety of different agents, dosages and strategies of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: a network meta-analysis of randomized controlled trials

Autologous Retinal Transplantation for Primary and Refractory Macular Holes, and Macular Hole Retinal Detachments: The Global Consortium

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial

Efficacy of a Treat-and-Extend Regimen With Ranibizumab in Patients With Neovascular Age-Related Macular Disease: A Randomized Clinical Trial